立方制药：股票交易异常波动公告

Core Viewpoint - The stock of Lifan Pharmaceutical experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days [1] Summary by Relevant Sections - Stock Performance The company's stock closed with a price increase of over 20% on August 15, 18, and 19, 2025, indicating significant market activity [1] - Company Operations The company confirmed that its recent operational status is normal, and there have been no significant changes in the internal or external business environment [1] - Disclosure of Information Lifan Pharmaceutical stated that there are no corrections or supplements needed for previously disclosed information, and there are no undisclosed significant matters related to the company by the company, its controlling shareholders, or actual controllers [1]